| Mr Jerry William Hussong, DDS MD | |
|
500 S Chipeta Way, Salt Lake City, UT 84108-1221 | |
| (801) 583-2787 | |
| (801) 584-5141 |
| Full Name | Mr Jerry William Hussong |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 500 S Chipeta Way, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346201209 | NPI | - | NPPES |
| 200225018 | Medicaid | NV |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jerry William Hussong, DDS MD 500 S Chipeta Way, Salt Lake City, UT 84108-1221 Ph: (801) 583-2787 | Mr Jerry William Hussong, DDS MD 500 S Chipeta Way, Salt Lake City, UT 84108-1221 Ph: (801) 583-2787 |
News Archive
When the HOPE VI community revitalization project in the disadvantaged Birmingham, Ala., neighborhood of Ensley reached the phase of building walking and biking paths, green spaces, and improved lighting in 2010, two things happened, according to a new study: First, residents developed specific expectations that leisure exercise would become more plausible, and then they followed through and got out there.
SuperGen Inc. announced today that the Food and Drug Administration (FDA) has officially accepted the Orathecin™ (rubitecan) capsules' New Drug Application (NDA) for filing. Orathecin, an investigational anticancer compound, is an oral chemotherapy agent that has been investigated as a treatment for pancreatic cancer patients who have failed at least one prior chemotherapy.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.
With unemployment rates remaining at an all-time high, one in five Americans chose not to seek medical care for a recent illness or injury, with four out of 10 citing cost as the primary factor, according to a Deloitte Center for Health Solutions survey of more than 4,000 adults in the United States.
› Verified 6 days ago
Dr. Bryce J. Parkinson, DO, MBA Pathology Medicare: Not Enrolled in Medicare Practice Location: 15 N Medical Dr Ste 1100, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Yahya Daneshbod, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 15 N Medical Dr Ste 1100, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Robert E. Rogers, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: Eccles Insititute Of Human Genetics: 15 N Medical Dr., Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Dr. Melissa Hankins Cessna, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 8th Avenue & C Street, Salt Lake City, UT 84143 Phone: 801-408-1784 Fax: 801-408-5196 | |
Kajsa Elizabeth Affolter, Pathology Medicare: Accepting Medicare Assignments Practice Location: University Of Utah Hospital, 50 North Medical Drive, Salt Lake City, UT 84132 Phone: 801-581-2507 | |
David R. Anderson, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: Eccles Insititute Of Human Genetics: 15 N Medical Dr., Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Peter E. Jensen, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2507 |